• article not found
  • Filters close
    Released: 26-Sep-2024 9:30 AM EDT
    Dana-Farber Cancer Institute Leads the Launch of IGNITE Consortium to Eradicate Health Inequities in Pediatric Cancer Care
    Dana-Farber Cancer Institute

    In a bold step toward addressing the stark disparities in pediatric cancer care, Dana-Farber Cancer Institute is taking the lead in launching IGNITE—the first national, pediatric hematology-oncology health equity research consortium. This groundbreaking initiative aims to eradicate inequities for children, adolescents, and young adults diagnosed with cancer or blood disorders via the rapid development and evaluation of policy-relevant, evidence-based and community informed health equity interventions.

    Newswise: Unlocking the Potential of Electrochemical Nitrate Reduction: A New Catalyst Approach
    Released: 26-Sep-2024 9:05 AM EDT
    Unlocking the Potential of Electrochemical Nitrate Reduction: A New Catalyst Approach
    Chinese Academy of Sciences

    In a major step toward sustainable chemistry, scientists have uncovered a new way to significantly boost the electrochemical reduction of nitrate to ammonia through the in-situ evolution of electrocatalysts. This breakthrough provides a cleaner alternative to the traditional ammonia synthesis process and a solution to the critical issue of nitrate pollution in water systems.

    Released: 26-Sep-2024 9:05 AM EDT
    New MSU Research Shows How Some Agriculture Practices Impact Food Safety, Health
    Michigan State University

    Agriculture is the world’s largest industry. It employs more than one billion people and generates over $1.3 trillion dollars’ worth of food annually, but some farm practices have serious negative impacts on the environment, which is why sustainable agricultural practices have been championed.

    23-Sep-2024 9:00 AM EDT
    Pregnant Women Who Sleep Less Than 7 Hours a Night May Have Children with Developmental Delays
    Endocrine Society

    Pregnant women who do not get enough sleep may be at higher risk of having children with neurodevelopmental delays, according to new research published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.

    Released: 26-Sep-2024 8:45 AM EDT
    2024 WDF Workshop Concludes with Record Attendance and Groundbreaking Innovations
    Coin Laundry Association

    CLA, formerly the Coin Laundry Association, welcomed nearly 300 industry professionals to the 2024 WDF Workshop, held Sept. 18-20 at the Grand Hyatt in downtown Nashville.

    Newswise: Alarming Surge: Global Crisis of Childhood Overweight and Obesity
    Released: 26-Sep-2024 8:30 AM EDT
    Alarming Surge: Global Crisis of Childhood Overweight and Obesity
    Florida Atlantic University

    Since 1990, childhood obesity has nearly doubled globally, with the U.S. at the forefront. In Southern Europe, 10-15% of children are obese, while Asia has nearly half of all overweight kids under 5. Nearly 70% of the average U.S. child's diet consists of ultra-processed foods, which are increasingly consumed by children under 24 months, raising obesity risks and reducing immunological protection. Addressing pediatric obesity requires a multifaceted approach from tackling the influence of social media and advertising on children’s food choices to increasing physical activity.

    Newswise: hurricane-impact-on-mosquito-population-hero-940x529.jpg
    Released: 26-Sep-2024 8:05 AM EDT
    Hurricane Impacts on Mosquito Populations
    University of Miami

    University of Miami health geographer Imelda Moise led a study that found mosquito populations in Miami-Dade County increased dramatically after Hurricane Irma.

    Released: 26-Sep-2024 8:05 AM EDT
    NEUROMARK® Treatment for Chronic Rhinitis Yields Significant Clinical Improvements
    Neurent Medical

    PARAGON Study Shows NEUROMARK® Treatment Benefits Allergic and Nonallergic Rhinitis Patients

    Released: 26-Sep-2024 6:00 AM EDT
    Uso De Tesoura Molecular Para Aprimorar a Terapia Com CéLulas CAR-T
    Mayo Clinic

    Pesquisadores da Mayo Clinic investigaram as bases moleculares do câncer e descobriram uma nova razão pela qual o receptor de antígeno quimérico (terapia com células CAR-T) não funciona em alguns pacientes. Essa descoberta estimulou novas estratégias que incorporam anticorpos e edição genética para melhorar os resultados desse tratamento inovador para os pacientes. Esta pesquisa do Dr. Saad Kenderian, consultor em hematologia da Mayo Clinic, foi publicada na Nature Communications.

    Released: 26-Sep-2024 6:00 AM EDT
    Uso De Tijeras Moleculares Para Mejorar La Terapia Con CéLulas CAR-T
    Mayo Clinic

    Investigadores de Mayo Clinic investigaron las bases moleculares del cáncer y descubrieron una nueva razón por la cual el receptor de antígeno quimérico (terapia con células CAR-T) no funciona en algunos pacientes. Este hallazgo estimuló nuevas estrategias que incorporan anticuerpos y edición genética para mejorar los resultados de este tratamiento innovador para los pacientes. Esta investigación del Dr. Saad Kenderian, consultor en hematología de Mayo Clinic, fue publicado en Nature Communications.

    Released: 26-Sep-2024 3:00 AM EDT
    استخدام المقص الجزيئي لتحسين العلاج بالخلايا التائية ذات مستقبلات المستضد الخيمرية
    Mayo Clinic

    روتشستر، ولاية مينيسوتا — توصل باحثو مايو كلينك إلى الأسس الجزيئية للسرطان واكتشفوا سببًا جديدًا لفشل مستقبلات المستضد الخيمرية (العلاج بالخلايا التائية) مع بعض المرضى. وقد عزز هذا الاكتشاف وضع استراتيجيات جديدة تدمج الأجسام المضادة وتعديل الجينات لتحسين نتائج هذا العلاج المتقدم للمرضى. نُشر هذا البحث الذي أجراه سعد كينديريان، بكالوريوس الطب والجراحة، استشاري طب الدمويات في مايو كلينك، في مجلة نيتشر كوميونيكيشنز (Nature Communications).

    Newswise: Alternating Currents for Alternative Computing with Magnets
    Released: 26-Sep-2024 1:05 AM EDT
    Alternating Currents for Alternative Computing with Magnets
    University of Vienna

    A new study conducted at the University of Vienna, the Max Planck Institute for Intelligent Systems in Stuttgart, and the Helmholtz Centers in Berlin and Dresden takes an important step in the challenge to miniaturize computing devices and to make them more energy-efficient.

    Newswise: In an Era of Climate Change, Clean Water and Reliable Water Storage for Floods and Droughts Is a Possibility!
    Released: 26-Sep-2024 12:00 AM EDT
    In an Era of Climate Change, Clean Water and Reliable Water Storage for Floods and Droughts Is a Possibility!
    National Research Council of Science and Technology

    Dr. Seongpil Jeong and Kyungjin Cho of the Center for Water Cycle Research at the Korea Institute of Science and Technology (KIST) have developed an aquifer storage technique that could improve the potential for stable water storage.

    Released: 25-Sep-2024 7:05 PM EDT
    CSUF Ranks in the Top 10 Among National Universities for Social Mobility
    California State University, Fullerton

    U.S. News & World Report Announces 2025 Best Colleges Rankings

    Newswise: NEJM: Results From Targeted Therapy for Ulcerative Colitis Study
    Released: 25-Sep-2024 7:05 PM EDT
    NEJM: Results From Targeted Therapy for Ulcerative Colitis Study
    Cedars-Sinai

    An international placebo-controlled study led by Cedars-Sinai suggests that a targeted drug therapy that was developed by researchers at Cedars-Sinai is safe and effective at helping people with moderate to severe ulcerative colitis reach clinical remission.

    Newswise: AI-Guided Experiments Speed Scientific Discovery
    Released: 25-Sep-2024 7:05 PM EDT
    AI-Guided Experiments Speed Scientific Discovery
    Pacific Northwest National Laboratory

    Finding a needle in a haystack is the quintessentially impossible task. But what if new tools could make it straightforwardly achievable? Imagine if, instead of searching through everything by hand, you could portion out small piles of hay and use magnets.

    Released: 25-Sep-2024 5:05 PM EDT
    Patients With Moderate-to-Severe Ulcerative Colitis May Find Significant Relief as New Treatment Option Shows Good Results in Clinical Trial
    Mount Sinai Health System

    A phase 2 trial of a monoclonal antibody known as tulisokibart for moderate-to-severe ulcerative colitis (UC) showed promising results for those who have not responded to conventional inflammatory bowel disease (IBD) treatment. The results were reported Thursday, September 26, in The New England Journal of Medicine.

    24-Sep-2024 1:35 PM EDT
    Single-Dose Gene Therapy is Potentially Life-Changing for Adults with Hemophilia B
    Perelman School of Medicine at the University of Pennsylvania

    Adults with hemophilia B saw their number of bleeding episodes drop by an average of 71 percent after a single infusion of gene therapy, according to the results of an international Phase III clinical trial published today in the New England Journal of Medicine by researchers from the University of Pennsylvania Perelman School of Medicine and a multicenter group of investigators.

    Newswise: When a Child Hurts, Validating Their Pain May Be the Best First Aid
    Released: 25-Sep-2024 4:30 PM EDT
    When a Child Hurts, Validating Their Pain May Be the Best First Aid
    University of South Australia

    In a new study from the University of South Australia, researchers say that parents and doctors should be mindful of how they talk to and treat children experiencing pain – no matter how big or small the injury – knowing that these foundational experiences can be carried forward into adulthood.



    close
    0.15065